SYNH News and Press, Syneos Health Inc. From 05/09/23

2023-05-09 17:55:11 ET Syneos Health ( NASDAQ: SYNH ) soared 19% in after hours trading on a report that a private equity consortium is in advanced talks to purchase the drug-research services company. Elliott Investment Management, Patient Square and Veritas Capital are i...

2023-05-09 11:48:17 ET Syneos Health ( NASDAQ: SYNH ) is scheduled to announce Q1 earnings results on Wednesday, May 10th, before market open. The consensus EPS Estimate is $0.66 (-34.7% Y/Y) and the consensus Revenue Estimate is $1.28B (-4.5% Y/Y). Over the last 2 yea...

2023-05-02 15:43:45 ET The U.S. Food and Drug Administration (FDA) on Tuesday issued a draft guidance to offer further support for decentralized clinical trials (DCTs) where studies for treatments and medical devices can take place beyond traditional trial sites. DCTs can lower the barr...

2023-05-02 06:33:00 ET Syneos Health ( NASDAQ: SYNH ) appointed Michael Bonello as CFO, effective July 1. The company said Stanford (Ben) Rudnick will continue to serve as interim CFO until that time. Bonello recently served as CFO of Clario, since 2021. ...

MORRISVILLE, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael Bonello as Chief Financial Officer, effective July 1, 2023. Stanford (Ben) Rudnick will continue to...

2023-05-01 13:10:00 ET Summary CashFlow Hunter returns to discuss launching his new Investing Group, Catalyst Hedge Investing. Coinbase not evolving from early mover status in crypto; Bitcoin a solution looking for a problem. 3M not a difficult short, dividend at risk. Spe...

MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial results on Wednesday, May 10th, 2023, prior to its earnings call at 8:00 a.m. ET. ...

2023-04-12 17:19:34 ET Summary Dealreporter article says that multiple PE firms are bidding for the company and even named advisors the company has hired. Private equity math works given relatively low current leverage and high cash generation. Even though the stock is decentl...

2023-04-10 10:47:50 ET Syneos Health ( NASDAQ: SYNH ) jumped 14% on a report that a handful of private equity firms are said to be interested in the contract research organization. The sales process, which is in its second round, has garnered the interest of at least four ...

MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced it has been awarded the Vaccine Industry Excellence Award for Best Contract Research Organization (CRO). Presente...